You are here: Home » Companies » News
TechM profit declines over high costs, beats estimates on revenue front
Asset quality worries weigh on Bandhan Bank's stock as NPAs spike
Business Standard

Glaxosmithkline Pharma Q1 consolidated net profit up 8% at Rs 116 crore

Drug manufacturers GlaxoSmithKline on Monday said its consolidated net profit increased to Rs 116 crore in the first quarter. Shares of the company closed at Rs 1,726.20 on BSE, said reports

Topics
GlaxoSmithKline | GlaxoSmithKline Pharmaceuticals | Drug makers in India

Press Trust of India  |  New Delhi 



GlaxoSmithKline, gsk
GSK

Pharmaceuticals on Monday said its consolidated net profit increased by 8 per cent to Rs 116 crore in the first quarter ended on June 30, 2022.

The drug firm had reported a net profit of Rs 107 crore in the April-June quarter of the previous year.

Revenue from operations rose to Rs 745 crore as against Rs 718 crore in the year-ago period, Pharmaceuticals said in a regulatory filing.

"Our results reflect good momentum across general medicines and vaccines during the quarter. We have delivered strong underlying growth with market share gains across focus brands," Pharmaceuticals MD Sridhar Venkatesh noted.

The drug firm is a subsidiary of GSK plc, a global biopharma company.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.


We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, July 25 2022. 20:10 IST

.